This study therefore shows that, differently from previously stated, the SDHA-mutant GIST patient is almost exclusively a germline SDHA-variant carrier that is prone to develop the tumor throughout his entire life and not just in his early adulthood (7, 10–12, 14). This evidence concerns the gene SDHA and neoplasm.